NCL expression was associated with the grade and clinical stage in glioblastoma, hepatocellular carcinoma, and non-small-cell lung cancer [15,43], whereas no significant difference was observed in pancreatic ductal carcinoma and gastric cancer [40,41]. The gene discussed is NUCLEOLIN; the disease is gastric cancer.